Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-04-05 @ 5:48 AM
Study NCT ID:
NCT05459532
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2022-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa
Sponsor:
University of Witwatersrand, South Africa
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EZ-SS-029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |